Normal Vaginal Delivery. Spontaneous vertex delivery
Conditions
Interventions
Intervention 1: All patients in first group receive 10 units of oxytocin by infusion. Oxytocin initiated equal to 2mu/min and increased 2mu/min every 15 minutes up to mg 32mu/min or until contractions
Treatment - Other
All patients in first group receive 10 units of oxytocin by infusion. Oxytocin initiated equal to 2mu/min and increased 2mu/min every 15 minutes up to mg 32mu/min or until contractions of uterine reac
All women in second group will receive 10 units of oxytocin by infusion. Oxytocin initiated equal to 2mu/min and increased 2mu/min every 15 minutes up to mg 32mu/min or until contractions of uterine r
Sponsors
Vice chancellor for research, Semnan University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: Singleton pregnancy; Vertex presentation; Estimated weight 34 weeks; Abscence of any contraindication for NVD. Exclusion criteria: Any contraindication for normal vaginal delivery; Any contraindication for administration of Oxytocin such as Malpresentation, Placenta Previa; Previous cesarean section; Cervix surgery; Twin or multiple pregnancy; Uncertain fetal heart rate.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Active delivery phase. Timepoint: Every 15 minutes after intervention. Method of measurement: Clinical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cervix dilatation; Fetal Heart Rate Patterns. Timepoint: 2 hours after intervention. Method of measurement: Clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Sina
Semnan University of Medical Sciences
Outcome results
None listed